Antihistamines in topical preparations.
D000588:Amines / Q000009:adverse effects; D003877:Dermatitis, Contact / Q000209:etiology*; D004983:Ethanolamines / Q000009:adverse effects; D005029:Ethylenediamines / Q000009:adverse effects; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D004366:Nonprescription Drugs / Q000009:adverse effects; D009824:Ointments; D010632:Pheniramine / Q000009:adverse effects; D010640:Phenothiazines / Q000009:adverse effects; D010879:Piperazines / Q000009:adverse effects; D012996:Solutions
D000588:Amines; D004983:Ethanolamines; D005029:Ethylenediamines; D006634:Histamine H1 Antagonists; D004366:Nonprescription Drugs; D009824:Ointments; D010640:Phenothiazines; D010879:Piperazines; D012996:Solutions; D010632:Pheniramine